Related Experiment Videos

RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho

M V Barone1, L Sepe, R M Melillo

  • 1Centro di Endocrinologia ed Oncologia Sperimentale del CNR, c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli "Federico II", via S. Pansini 5, Naples, Italy.

Oncogene
|November 13, 2001
PubMed

Insights

Thyroid papillary carcinomas with RET/PTC1 rearrangements induce stress fibers via Rho GTPase activity. This actin reorganization is specific to thyroid cells and linked to cell survival.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Thyroid papillary carcinomas often feature RET/PTC rearrangements, leading to constitutively active RET kinase.
  • The RET/PTC1 oncogene's role in cellular actin organization is not fully understood.

Purpose of the Study:

  • To investigate the effects of the RET/PTC1 oncogene on actin reorganization in thyroid epithelial cells.
  • To determine the specific signaling pathways and cell types involved in RET/PTC1-induced actin changes and their impact on cell survival.

Main Methods:

  • Analysis of actin stress fiber formation in PC Cl 3 rat thyroid epithelial cells expressing RET/PTC1.
  • Comparison with other oncogenes (Src, Ras, Raf) and RET variants (RET/MEN 2A).
  • Assessment of RET/PTC1-induced effects in different cell lines (human thyroid carcinoma, NIH3T3 fibroblasts, MCF7 mammary cells) and the role of Rho and Rac GTPases.

Main Results:

  • RET/PTC1 oncogene specifically induced prominent actin stress fibers in thyroid cells, unlike other oncogenes.
  • Stress fibers were observed in human thyroid papillary carcinoma cells with RET/PTC1 rearrangements.
  • RET/PTC1-mediated stress fiber formation and cell survival were dependent on Rho GTPase activity, but not Rac, and were cell type-specific.

Conclusions:

  • The chimeric RET/PTC1 oncogene drives unique actin reorganization and promotes thyroid cell survival through Rho GTPase signaling.
  • These findings highlight the cell type- and oncogene-specific roles of Rho in mediating RET/PTC1 effects in thyroid cancer.

Related Concept Videos